Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CytoDyn Inc CYDY

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The Company is studying leronlimab in multiple therapeutic areas, including... see more

OTCQB:CYDY - Post Discussion

CytoDyn Inc > WOW WTF?
View:
Post by BodDayTrader99 on Sep 01, 2022 3:52pm

WOW WTF?

What a bad fkg bad apple is this stock?  Keeps going down the fkg drain!
Comment by Pandora on Nov 23, 2022 3:19pm
Used to watch this stock on the Yahoo board but they redesigned that board and it is a total mess. I can't even figure out how to get into it. It says "sign up" or "log in" to access but I am signed up and logged in. The conversations you see are mostly all days old and contain quite a few complaints about the new design. At least they figured out how to get in.
Comment by Pandora on Dec 29, 2022 10:08am
By the looks of price and volume it seems like expectations for today's update are a "zero". I hope it is a little bit better than that, or this is a write off, which many people have alraedy done. Update at 8 a.m. Pacific time.
Comment by Pandora on Dec 29, 2022 4:09pm
Seems like the market was right. Another nothing burger. Offhand I would have to give these guys an 'F' for rating their ability to communicate. We get an announcement about once a month and after each one the share price dumps.